Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Sep 16, 2020 at 9:50 AM EDT

Why This Interim Liver Study Is Huge for Arrowhead Pharma

Arrowhead Pharmaceuticals has announced positive interim 24-week liver biopsy results in four subjects from its midstage study of ARO-AAT. Shares…

Jon C. Ogg | Sep 15, 2020 at 1:01 PM EDT

Beyond Mesothelioma, Multiple Sclerosis Could Help Atara’s Stock Soar Exponentially

On Tuesday, Canaccord Genuity reiterated its rating on Atara Biotherapeutics and raised its wildly bullish target price even higher.

Chris Lange | Sep 15, 2020 at 12:35 PM EDT

Why This Epilepsy Study Is Huge for Marinus Pharmaceuticals

The announcement of positive topline results in a late-stage epilepsy trial prompted a rally in Marinus Pharmaceuticals shares on Tuesday.

Chris Lange | Sep 15, 2020 at 10:20 AM EDT

Why This FDA Win for Ardelyx Is Definitely a ‘Sell the News’ Moment

Companies winning approval from the FDA or beating a trial are expected in some cases. If investors already have priced…

Lee Jackson | Sep 15, 2020 at 7:19 AM EDT

Jefferies Top Growth Stocks to Buy Include 4 Red-Hot Health Care Companies

These four high-conviction health care stock ideas from the analysts at Jefferies all make sense for investors looking to gain…

Douglas A. McIntyre | Sep 15, 2020 at 6:49 AM EDT

Global COVID-19 Cases Near 30 Million, Millions Too Low

When 30 million confirmed COVID-19 cases globally are reached later this week, there will be a suspicion that the number…

Chris Lange | Sep 14, 2020 at 3:45 PM EDT

How Cassava Sciences Could Be Pioneering a Groundbreaking Alzheimer’s Treatment

Cassava Sciences reported good results from a mid-stage study of its sumifilam treatment for Alzheimer's disease. Shares soared on the…

Chris Lange | Sep 14, 2020 at 9:57 AM EDT

Are Immunomedics Shareholders Getting Enough in the Acquisition?

Immunomedics shares more than doubled on Monday after the firm announced that it would be acquired by Gilead Sciences in…

Douglas A. McIntyre | Sep 13, 2020 at 5:55 AM EDT

It’s 122 Degrees In This City Today

Temperatures have set records around the world recently, and the warmest places are routinely over 110 degrees F during the…

Chris Lange | Sep 11, 2020 at 10:05 AM EDT

Short Sellers Hike Their Bets in Major Biotechs

The August 31 short interest data has been compared with the previous report, and short interest in most of these…

Douglas A. McIntyre | Sep 11, 2020 at 6:22 AM EDT

Widely Regarded Model Puts Global COVID-19 Deaths at 2.8 Million This Year

One of the most widely respected COVID-19 case models forecasts 2.8 million deaths by the end of the year. That…

Chris Lange | Sep 10, 2020 at 10:09 AM EDT

This Late-Stage Study Is Giving Satsuma Pharma Stock Migraines

After Satsuma Pharmaceuticals reported disappointing late-stage results from its migraine treatment, and its shares were absolutely crushed Thursday morning.

Chris Lange | Sep 10, 2020 at 9:40 AM EDT

Innoviva Wins Another Key FDA Approval for Asthma

The FDA has approved Innoviva's treatment of asthma and for patients with chronic obstructive pulmonary disease, the company announced, giving…

Chris Lange | Sep 10, 2020 at 7:55 AM EDT

5 Very Undervalued Large Cap Biotech Stocks That Could Explode in 2021

Practically any biotech company attempting almost anything COVID-19 related has seen massive gains. However, there is likely more to come…

Chris Lange | Sep 9, 2020 at 1:17 PM EDT

iBio Takes Another Big Step in the Fight Against COVID-19

iBio has announced that it has selected a vaccine to advance for the prevention of infection by the coronavirus that…

1 … 41 42 43 44 45 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Why This Interim Liver Study Is Huge for Arrowhead Pharma

Beyond Mesothelioma, Multiple Sclerosis Could Help Atara’s Stock Soar Exponentially

Why This Epilepsy Study Is Huge for Marinus Pharmaceuticals

Why This FDA Win for Ardelyx Is Definitely a ‘Sell the News’ Moment

Jefferies Top Growth Stocks to Buy Include 4 Red-Hot Health Care Companies

Global COVID-19 Cases Near 30 Million, Millions Too Low

How Cassava Sciences Could Be Pioneering a Groundbreaking Alzheimer’s Treatment

Are Immunomedics Shareholders Getting Enough in the Acquisition?

It’s 122 Degrees In This City Today

Short Sellers Hike Their Bets in Major Biotechs

Widely Regarded Model Puts Global COVID-19 Deaths at 2.8 Million This Year

This Late-Stage Study Is Giving Satsuma Pharma Stock Migraines

Innoviva Wins Another Key FDA Approval for Asthma

5 Very Undervalued Large Cap Biotech Stocks That Could Explode in 2021

iBio Takes Another Big Step in the Fight Against COVID-19

‘I thought the numbers would be much worse’: Trump’s surprising admission as gas prices spike 50%

Elon’s Terafab Is Moving at “Light Speed” — and That Could Mean Big Things for Tesla

At 59, Tapping a $1.5 Million 401(k) First Could Trigger $55,000 in Penalties and Taxes

At 59, Tapping a $1.5 Million 401(k) First Could Trigger $55,000 in Penalties and Taxes

Suze Orman to 50-Year-Old With $33K Divorce Debt Eyeing 401(k) Withdrawal: 'Don't Do It.'

8 billionaires who fled California before the “Wealth Tax” hit — and one who didn’t

‘I thought the numbers would be much worse’: Trump’s surprising admission as gas prices spike 50%

Health and Healthcare Articles

All Health and Healthcare Articles

Why This Interim Liver Study Is Huge for Arrowhead Pharma

Beyond Mesothelioma, Multiple Sclerosis Could Help Atara’s Stock Soar Exponentially

Why This Epilepsy Study Is Huge for Marinus Pharmaceuticals

Why This FDA Win for Ardelyx Is Definitely a ‘Sell the News’ Moment

Jefferies Top Growth Stocks to Buy Include 4 Red-Hot Health Care Companies

Global COVID-19 Cases Near 30 Million, Millions Too Low

How Cassava Sciences Could Be Pioneering a Groundbreaking Alzheimer’s Treatment

Are Immunomedics Shareholders Getting Enough in the Acquisition?

It’s 122 Degrees In This City Today

Short Sellers Hike Their Bets in Major Biotechs

Widely Regarded Model Puts Global COVID-19 Deaths at 2.8 Million This Year

This Late-Stage Study Is Giving Satsuma Pharma Stock Migraines

Innoviva Wins Another Key FDA Approval for Asthma

5 Very Undervalued Large Cap Biotech Stocks That Could Explode in 2021

iBio Takes Another Big Step in the Fight Against COVID-19

‘I thought the numbers would be much worse’: Trump’s surprising admission as gas prices spike 50%

Elon’s Terafab Is Moving at “Light Speed” — and That Could Mean Big Things for Tesla

At 59, Tapping a $1.5 Million 401(k) First Could Trigger $55,000 in Penalties and Taxes

Featured Reads

At 59, Tapping a $1.5 Million 401(k) First Could Trigger $55,000 in Penalties and Taxes

Suze Orman to 50-Year-Old With $33K Divorce Debt Eyeing 401(k) Withdrawal: 'Don't Do It.'